Istari Oncology

Istari Oncology

Biotechnology, 430 Davis Dr, Durham, North Carolina, 27560, United States, 1-10 Employees

istarioncology.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 91********

Who is ISTARI ONCOLOGY

Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors...

Read More

map
  • 430 Davis Dr, Durham, North Carolina, 27560, United States Headquarters: 430 Davis Dr, Durham, North Carolina, 27560, United States
  • 2016 Date Founded: 2016
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from ISTARI ONCOLOGY

Istari Oncology Org Chart and Mapping

Employees

Cyndy White

Part-Time Accounting Consultant

Will Nichols

Intern at Istari Oncology

Lori Mixson

Head of Biostatistics

Robert Melfi

Chief of Staff & Director of Program Management

Jessica Sorrentino

Vice President, Translational Medicine

Kacy Smith

Director of Quality Assurance

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Istari Oncology

Answer: Istari Oncology's headquarters are located at 430 Davis Dr, Durham, North Carolina, 27560, United States

Answer: Istari Oncology's phone number is 91********

Answer: Istari Oncology's official website is https://istarioncology.com

Answer: Istari Oncology's revenue is $5 Million to $10 Million

Answer: Istari Oncology's SIC: 8731

Answer: Istari Oncology has 1-10 employees

Answer: Istari Oncology is in Biotechnology

Answer: Istari Oncology contact info: Phone number: 91******** Website: https://istarioncology.com

Answer: Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The company was founded by Darell Bigner, MD, and Matthias Gromeier, MD, of Duke University Medical Center in 2016. Both are leaders in their respective research fields of virology, immunology, monoclonal development and clinical medicine, particularly in the treatment of brain tumors.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access